I have been captivated by the promise of transforming cancer research through the development of a groundbreaking drug screening platform for glioblastoma cells. In the pursuit of my doctoral thesis, I am constructing a novel glioblastoma-brain organoid model that integrates advanced culturing techniques and induced pluripotent stem cell (iPSC)-derived brain organoids. This platform is not only expected to capture the intricate cellular interactions and characteristics of glioblastoma but also aims to encapsulate the heterogeneity and microenvironment components within the tumor.
I have been captivated by the promise of transforming cancer research through the development of a groundbreaking drug screening platform for glioblastoma cells. In the pursuit of my doctoral thesis, I am constructing a novel glioblastoma-brain organoid model that integrates advanced culturing techniques and induced pluripotent stem cell (iPSC)-derived brain organoids. This platform is not only expected to capture the intricate cellular interactions and characteristics of glioblastoma but also aims to encapsulate the heterogeneity and microenvironment components within the tumor.